Want to track 1672 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ascletis Pharma Inc. (1672) Statistics
Valuation metrics
Market Cap 1.63B
Enterprise value 8.6B
Trailing P/E (ttm) -25.8
Forward P/E -
PEG ratio 0.75
Price/Sales (ttm) 4,951.84
Price/Book (mrq) 4.87
Enterprise Value/Revenue 4,242.29
Enterprise Value/EBITDA -18.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.79M
Average volume (90 days) 2.89M
Price summary
52-Week low 7.95
52-Week high 19.86
Beta -
50-Day moving average 9.93
200-Day moving average 13.72
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -177.46%
Operating margin -238.54%
Operational effectiveness
Return on assets -0.17%
Return on equity -0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.94
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 15.05%
Book value per share (mrq) 1.97
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
